Home Tags Trastuzumab

Tag: trastuzumab

MI130004 Demonstrates Anticancer Activity in HER2-expressing Tumors

Novel, effective, safe and efficient compounds of natural origin t help fight human disease are hard to find. ver the last decades, scientists have...

Antibody-drug Conjugate Potential for Metastatic Breast Cancer Treatment Shown Through Results...

In 2012, an estimated 2,975,314 women were living with breast cancer, representing about 12% of all new cancer cases and 25% of all cancers...
Photo: Before the pandemic - the annual meeting of the AACR/American Association for Cancer Research: Photo courtesy: 2015 AACR/Todd Buchanan.

XMT-1522 Demonstrates Potent Activity in Low HER2-Expressing Tumor Models

Preclinical data for XMT-1522, a novel HER2-targeting therapy based on Mersana Therapeutics' Dolaflexin platform, the company's most advanced Fleximer® proprietary immunoconjugate technology, demonstrates significant anti-cancer activity...

EORTC Trial Starts for Elderly with HER-2 Positive Metastatic Breast Cancer

Despite the fact that the incidence of cancer is many fold higher in persons over 65 years of age, we still have an inadequate...

Monoclonal Antibodies (mAbs), the “Magic Bullets” of Cancer Care, Are Now...

Monoclonal Antibodies (mAbs), once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way,...